List of works by Markus Cornberg

A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B

scientific article published on 29 June 2018

A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B

scientific article published on 26 July 2018

A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C.

scientific article published on 15 August 2014

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

scientific article published on July 2011

A transient early HBV DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV RNA and HBsAg reduction

scientific article published on 13 November 2020

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

scientific article published on February 2016

Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.

scientific article published on 26 December 2008

All-oral, interferon-free therapies for patients with chronic genotype 1 hepatitis C virus infection

scientific article published on 12 November 2014

Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.

scientific article published on June 2015

Anti-HDV IgM as a marker of disease activity in hepatitis delta

scientific article

Antiviral treatment and liver-related complications in hepatitis delta

scientific article

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

scientific article

Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data

scientific article published on 29 April 2020

Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites

scientific article published on 24 September 2018

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

scientific article published on 25 July 2019

CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections

scientific article published on 17 February 2010

CD8 memory T cells: cross-reactivity and heterologous immunity.

scientific article

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

scientific article published on 02 April 2020

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection

scientific article published in June 2006

Challenges in warranting access to prophylaxis and therapy for hepatitis B virus infection.

scientific article published on January 2017

Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies

scientific article published on 16 June 2020

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity.

scientific article published on 11 June 2018

Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection.

scientific article published on 28 July 2014

Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells

scientific article published on 14 May 2019

Clearance of chronic HCV infection during acute delta hepatitis.

scientific article

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response

scientific article (publication date: 11 June 2007)

Clinical Practice Guidelines of the European Association for the study of the Liver - Advancing methodology but preserving practicability

scientific article published on 09 November 2018

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).

scientific article published on 29 September 2017

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor Simeprevir and frequently used concomitant medications

scientific article published on 18 January 2018

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

scientific article published on 13 April 2016

Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell response.

scientific article published on 20 December 2013

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study

scientific article

Comprehensive phenotyping of regulatory T cells after liver transplantation.

scientific article published on 20 January 2015

Compromised function of natural killer cells in acute and chronic viral hepatitis.

scientific article published on 23 October 2013

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients

scientific article published on 01 September 2018

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.

scientific article published on 26 January 2011

Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.

scientific article published on 10 June 2008

Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection.

scientific article published on 8 February 2016

Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis

scientific article

Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany

scientific article published on 18 April 2016

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections

scientific article published on 8 May 2017

Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E

scientific article published on 14 June 2019

Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial

scientific article published on 22 March 2013

Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir.

scientific article published on 10 November 2013

Development and evaluation of a baseline-event-anticipation score for hepatitis delta

scientific article

Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens

scientific article published on 01 January 2019

Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C.

scientific article published on 28 September 2016

Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients

scientific article published on 13 April 2015

Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras.

scientific article published on 30 January 2009

Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.

scientific article

Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.

scientific article published on 26 November 2015

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

scientific article

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study

scientific article published on February 2006

Editorial: which factors influence HBsAg levels in HBV-infected patients?

scientific article published on 01 August 2020

Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis

scientific article published on 01 October 2004

Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.

scientific article published on 9 January 2009

Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals

scientific article published on 10 April 2014

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

scientific article published on 2 February 2015

Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting

scientific article

Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses

scientific article published on 08 July 2019

Embedding T cells in the matrix.

scientific article

Entecavir - options and obstacles of an effective treatment for chronic hepatitis B

scientific article published on 18 December 2009

Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.

scientific article published in January 2007

Fate of goblet cells in experimental colitis

scientific article published in October 2002

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

scientific article published on 10 April 2020

Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy

scientific article published on 03 February 2020

Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.

scientific article published on 3 June 2015

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites

scientific article published on 13 March 2020

Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.

scientific article published on 2 February 2010

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.

scientific article published on 29 June 2007

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

scientific article published in June 2018

Global timing of hepatitis C virus elimination in high-income countries

scientific article published on 23 December 2019

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

scientific article published on 12 November 2019

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

scientific article published on 12 November 2019

HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination

scientific article published on 26 May 2020

HBsAg seroclearance with NUCs: rare but important.

scientific article published on 7 January 2014

HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection

scientific article published on 18 July 2018

Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.

scientific article published on 22 September 2006

Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.

scientific article published on 17 February 2015

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.

scientific article

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

scientific article published on 13 February 2010

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection

scientific article

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

scientific article published on 28 June 2011

Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B

article

Hepatitis B – Ein Ausblick auf aktualisierte Leitlinien

scientific article published on 6 February 2018

Hepatitis C in Germany: an analysis of statutory sickness funds claims data

scientific article

Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies

scientific article published on 15 December 2020

Hepatitis C virus core antigen testing in liver and kidney transplant recipients

scientific article published on 19 November 2013

Hepatitis C virus infection from the perspective of heterologous immunity.

scientific article published on 27 January 2016

Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.

scientific article published on 11 March 2009

Hepatitis C: individualised medicine versus one pill fits all.

scientific article published on 26 July 2016

Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

scientific article published on 15 July 2011

Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy

scientific article published on 04 September 2019

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

scientific article published in March 2012

Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E.

scientific article

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients

scientific article published on 01 January 2010

Hepatitis associated cryoglobulinemia

scientific article published on 01 March 2008

Hepatitis: No cure for hepatitis B and D without targeting integrated viral DNA?

scientific article published on 31 January 2018

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

scientific article published on May 2014

How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assays.

scientific article published on February 2014

Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.

scientific article published on 16 March 2018

Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver

scientific article published on 18 June 2019

Identification of Novel Population-Specific Cell Subsets in Chinese Ulcerative Colitis Patients Using Single-Cell RNA Sequencing

scientific article published on 02 February 2021

ImPortance of IP-10 in hepatitis B

scientific article published on 24 November 2015

Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry

scientific article published on 01 December 2018

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

scientific article published on 04 August 2020

Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.

scientific article published in March 2008

Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients

scientific article published on 06 November 2012

Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders

scientific article published on 19 March 2015

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome

scientific article

Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis

scientific article

Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss.

scientific article

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients

scientific article published on 21 December 2020

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

scientific article

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

scientific article published on 2 February 2010

Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up

scientific article published on 12 September 2017

Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

scientific article

Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy

scientific article published on 4 October 2017

Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis

scientific article published on 01 December 2009

Kurzfassung der aktualisierten S3-Leitlinie „Diagnostik und Therapie der Hepatitis B”

scientific article published on 01 August 2007

Laboratory requirements to diagnose viral hepatitis under the development of guidelines

scientific article published on 6 October 2016

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta

scientific article published on July 2014

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

scientific article

Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis

scientific article published on 01 January 2020

Letter: can persisting liver stiffness indicate increased risk of hepatocellular cell carcinoma after successful anti-HCV therapy? - authors' reply

scientific article published on 01 February 2016

Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.

scientific article published on August 2014

Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort

scientific article published on 08 April 2020

Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals

scientific article published on 27 June 2018

Long-term follow-up after successful interferon therapy of acute hepatitis C.

scientific article published on July 2004

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study

scientific article

Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.

scientific article

MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis

scientific article published on 03 February 2020

Making sense of muscle fatigue and liver lesions.

scientific article published in July 2007

Management of HBV and HBV/HDV-Associated Liver Cirrhosis

scientific article

Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity

scientific article published on June 2006

Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19

scientific article published on 06 April 2022

Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level

scientific article published on 12 February 2019

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

scientific article published in December 2002

NK cells in hepatitis C: role in disease susceptibility and therapy.

scientific article published on 11 October 2012

Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

scientific article

Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

article published in 2007

Natural killer cells act as rheostats modulating antiviral T cells

scientific article published on 20 November 2011

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C.

scientific article

New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014

scientific article published in April 2014

New kids on the block--step by step to an ideal HCV therapy

scientific article

New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations

scholarly article published 23 July 2021

New viral biomarkers for Hepatitis B: Are we able to change practice?

scientific article published on 01 November 2018

Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy

scientific article published on 14 June 2016

Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.

scientific article

PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C

scientific article

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

scientific article published on 01 March 2019

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting

scientific article published on 23 December 2015

Performance of Roche qualitative HEV assay on the cobas 6800 platform for quantitative measurement of HEV RNA

scientific article published on 27 June 2020

Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras

scientific article published on 25 June 2019

Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E

scientific article published on 19 June 2017

Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.

scientific article published on February 2012

Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.

scientific article published on 22 September 2008

Polyethylene glycol-interferon: current status in hepatitis C virus therapy

scientific article

Present and future therapy for hepatitis C virus

scientific article published on October 2006

Prevalence of HBV genotypes in Central and Eastern Europe

scientific article published on 01 October 2008

Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review

scientific article published on 28 August 2020

Private specificities of CD8 T cell responses control patterns of heterologous immunity

scientific article

Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011

scientific article

Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.

scientific article

Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection

scientific article published on 29 January 2010

Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.

scientific article published on November 2006

Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a

scientific article published on 18 December 2019

Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therap

scientific article published on 25 January 2018

Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)

scientific article published on 15 July 2022

Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment.

scientific article published on 28 September 2017

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis

scientific article published on 13 February 2020

Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection

scientific article published on 12 January 2017

Reappearance of Effector T Cells Predicts Successful Recovery from COVID-19

scientific article published on 15 May 2020

Reappearance of effector T cells is associated with recovery from COVID-19

scientific article published on 07 July 2020

Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C.

scientific article published on 13 January 2011

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

scientific article

Reply to Liaw

scientific article published on 01 October 2018

Reply to: “Serum HBsAg kinetics in clinical prediction”

scientific article published on 16 March 2017

Residual low HDV viremia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study

scientific article published on 20 November 2020

Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.

scientific article

Response to Taiwan is on track of accelerating hepatitis C elimination by 2025

scientific article published on 24 April 2020

Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection

scientific article published on 01 February 2019

Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.

scientific article published on 9 July 2016

Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites

scientific article published on 25 June 2020

Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.

scientific article published on 10 May 2017

Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study

scientific article published on 02 July 2020

Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)

scientific article published on 18 September 2020

Sofosbuvir: the final nail in the coffin for hepatitis C?

scientific article published on 15 March 2013

Soluble immune markers in the different phases of chronic hepatitis B virus infection

scientific article published on 01 October 2019

Specific infections in organ transplantation

scientific article

Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?

scientific article published in August 2008

Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?

scientific article published on 21 November 2017

Strategies to manage hepatitis C virus (HCV) disease burden.

scientific article published on May 2014

Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir.

scientific article published on 18 January 2017

Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis

scientific article published on 02 August 2019

Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity

scientific article published on 16 November 2015

Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis

scientific article published on 02 August 2019

Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseases.

scientific article

TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection

scientific article published on 23 October 2020

Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta

scientific article published on 24 July 2020

The German guideline for the management of hepatitis B virus infection: short version.

scientific article published in August 2008

The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells.

scientific article

The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.

scientific article published on 16 October 2013

The hepatitis E virus: a likely cause of extrahepatic diseases!

scientific article published on April 2016

The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients

scientific article published on 30 July 2019

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

scientific article published on May 2014

The role of HBsAg levels in the current management of chronic HBV infection

scientific article published on January 2014

The role of quantitative hepatitis B surface antigen revisited.

scientific article

Towards eradication of HBV: Treatment approaches and status of clinical trials

scientific article published in 2021

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

scientific article published on 27 December 2018

Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.

scientific article published on 9 June 2015

Treatment duration in acute hepatitis C: the issue is not solved yet

scientific article published on 01 October 2006

Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials

scientific article published on 18 July 2016

Treatment of acute hepatitis C-how to explain the differences?

scientific article published in August 2006

Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.

scientific article published on 05 September 2008

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

scientific article

Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA

scientific article

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study

scientific article published on 28 November 2005

Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab

scientific article published on 19 February 2018

Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C.

scientific article

UEG framework for the development of high-quality clinical guidelines

scientific article published on 02 September 2020

Unexplained jaundice after squirrel bite. It's not what you look at that matters, it's what you see (H. D. Thoreanu)

scientific article published on 01 September 2011

Unraveling the Hepatitis B Cure: A Hybrid AI Approach for Capturing Knowledge about the Immune System's Impact

scientific article published on 29 November 2023

Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry

scientific article published on 25 April 2020

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.

scientific article

What is new on HBsAg and other diagnostic markers in HBV infection?

scientific article published on 04 May 2017

When a respiratory pathogen turns to the skin: cutaneous tuberculosis in a lung transplant patient.

scientific article published on 22 April 2015

Which treatment options are validated for chronic viral hepatitis?

scientific article published in December 2013

Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C

scientific article published on 01 May 2004

[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)]

scientific article published on 14 January 2019

[Chronic hepatitis B and D (delta) : Current and future treatments].

scientific article

[Costs of guideline-based treatment of hepatitis B patients in Germany].

scientific article published on 15 August 2012

[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.].

scientific article published on 01 January 2011

[Diagnostics and therapy of hepatitis].

scientific article published in December 2009

[Hepatitis E virus infection: a paradigm shift?]

scientific article published on 25 May 2010

[Influence of a spontaneous bacterial peritonitis, nosocomial infections and acute-on-chronic liver failure on treatment revenues in patients with decompensated cirrhosis in Germany]

scientific article published on 18 September 2020

[Knowledge and management of hepatitis B virus infected patients in Germany]

scientific article published on 10 April 2012

[One pill for all HCV-genotypes?]

scientific article published on 16 March 2016

[Paradigmatic change in treatment of viral hepatitides]

scientific article published on 20 March 2012

[Prevention of virus hepatitis A to E]

scientific article published on 01 March 2011

[Step-by-step toward the perfect hepatitis C treatment for all genotypes]

scientific article published on 01 September 2015